Submission Deadline - 06/15/2024 11:59 PM Pacific (PST)
National Abstract Competition
If you are a researcher, community-based member organization, physician, nurse, social worker or someone working on behalf of people living with sickle cell disease and their families, the Sickle Cell Disease Association of America, Inc. would like to highlight your work at the 52nd Annual National Convention, October 23-26, 2024, in-person at the Loews Atlanta Hotel, Atlanta, GA.
To be eligible, abstracts must meet guidelines and be submitted by June 15, 2024. Late submissions will not be accepted. Abstracts will be reviewed and ranked by the national abstract review committee. We hope to notify you of acceptance beginning August 2, 2024. Abstract finalists will be judged during oral presentations and presented at the SCDAA Gala (Friday evening, October 25th)
“Best Abstract” in each category will be announced at the SCDAA 52nd Annual National Convention. Special awards for the best student and trainee abstracts will also be given.
Submission Instructions and Guidelines
Abstract text must be written in English and contain the following:
2024 Presentations, Topic Categories, and Examples
Categories for abstract judging are listed here. Trainee presentations are a subcategory of each topic. If your abstract seems to fit more than one topic category, please select a first choice and a second choice – the abstract judges will decide which category fits best.
Topic
Examples for sickle cell disease (SCD)
Public Health, Policy, and Implementing the NASEM 2020 report Sickle Cell Blueprint for Action
Describe ways to utilize the NASEM Report to promote SCD in Public Health, improve health policy on SCD, public awareness of SCD and SCT, health professionals’ awareness of SCD and SCT. Areas of interest include educational materials.
Community-Based Research
Research that takes place in community settings and involves community members in the design and implementation of research projects, demonstrates respect for the contributions of success that are made by community partners.
Basic and Translational Research
Mechanisms of SCD or SCT complications, scientific research to create new therapies, medical procedures, or diagnostics.
Clinical Research
Human subjects research based in the clinic or hospital to study the safety, effectiveness, and/or efficacy of medications, transplant, gene therapy, devices, or diagnostic products for human use. These may be used for prevention, treatment, or diagnosis, or for relieving symptoms of SCD or SCT.
Psychosocial Research
Psychosocial Research addressing the interrelation of behavioral, social, psychological, and other quality of life. factors involving SCD or SCT. Areas of interest include aging, caregiving, employment, health behaviors and fitness, independent living, self-management, and technology access.
Gene Therapy Hematopoietic Stem Cell Transplant
Results of clinical research. Patient journey, decision process, motivators, barriers, costs, or payment plans.
SCD Global Health
Work focused on sickle cell disease outside of USA
Sickle Cell Trait
Work focused on sickle cell Trait screening, awareness, or risks